Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2024 09:42 ET | Source: Research and Markets

Liver Cirrhosis Pipeline Insights, 2024: Featuring 45+ Companies and 50+ Pipeline Drugs, Including Elafibranor (Ipsen), Volixibat (Mirum Pharmaceuticals), and PVT201 (Parvus Therapeutics)

Dublin, April 26, 2024 (GLOBE NEWSWIRE) -- The "Liver Cirrhosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
April 11, 2024 11:06 ET | Source: Research and Markets

Cirrhosis Market and Pipeline Insights, 2024: Analysis of Emerging Drugs GXHPC 1 (GWOXI Stem Cell Applied Technology), LPCN 1148 (Lipocine), and Belapectin (Galectin Therapeutics)

Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Cirrhosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
March 25, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight

New York, USA, March 25, 2024 (GLOBE NEWSWIRE) -- Cirrhosis Clinical Trial Pipeline Insights Featuring 45+ Companies | DelveInsight The rise in the number of people suffering from cirrhosis can be...
May 04, 2021 04:03 ET | Source: Research and Markets

2021 Pipeline Analysis for Advanced Hepatocellular Carcinoma with CPB Liver Cirrhosis: Therapeutic Assessment, Unmet Needs and Impact of Drugs

Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Advanced Hepatocellular Carcinoma with CPB liver cirrhosis - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering....